337 related articles for article (PubMed ID: 15500713)
1. [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease].
Lu LL; Su Y; Duan CL; Zhao CL; Su YJ; Wu J; Zhao HY; Xu QY; Yang H
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1528-32. PubMed ID: 15500713
[TBL] [Abstract][Full Text] [Related]
2. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes.
Fan D; Shen Y; Kang D; Nakano I; Ozawa K
Chin Med J (Engl); 2001 Dec; 114(12):1276-9. PubMed ID: 11793852
[TBL] [Abstract][Full Text] [Related]
4. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease.
Lu L; Zhao C; Liu Y; Sun X; Duan C; Ji M; Zhao H; Xu Q; Yang H
Brain Res Brain Res Protoc; 2005 May; 15(1):46-51. PubMed ID: 15878150
[TBL] [Abstract][Full Text] [Related]
6. Cotransduction of tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes into cultured striatal cells using adeno-associated virus vectors.
Fan D; Kang D; Ogawa M; Nakano I; Nagatsu T; Kurtzman GJ; Ozawa K
Chin Med J (Engl); 1998 Dec; 111(12):1111-3. PubMed ID: 11263376
[TBL] [Abstract][Full Text] [Related]
7. The assays of activities and function of TH, AADC, and GCH1 and their potential use in ex vivo gene therapy of PD.
Duan CL; Su Y; Zhao CL; Lu LL; Xu QY; Yang H
Brain Res Brain Res Protoc; 2005 Dec; 16(1-3):37-43. PubMed ID: 16338639
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
[TBL] [Abstract][Full Text] [Related]
9. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
Sánchez-Pernaute R; Harvey-White J; Cunningham J; Bankiewicz KS
Mol Ther; 2001 Oct; 4(4):324-30. PubMed ID: 11592835
[TBL] [Abstract][Full Text] [Related]
10. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes.
Muramatsu S; Fujimoto K; Ikeguchi K; Shizuma N; Kawasaki K; Ono F; Shen Y; Wang L; Mizukami H; Kume A; Matsumura M; Nagatsu I; Urano F; Ichinose H; Nagatsu T; Terao K; Nakano I; Ozawa K
Hum Gene Ther; 2002 Feb; 13(3):345-54. PubMed ID: 11860702
[TBL] [Abstract][Full Text] [Related]
11. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector.
During MJ; Samulski RJ; Elsworth JD; Kaplitt MG; Leone P; Xiao X; Li J; Freese A; Taylor JR; Roth RH; Sladek JR; O'Malley KL; Redmond DE
Gene Ther; 1998 Jun; 5(6):820-7. PubMed ID: 9747462
[TBL] [Abstract][Full Text] [Related]
12. [Gene therapy for Parkinson's disease: studies in animal models].
Muramatsu S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1157-9. PubMed ID: 12235825
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for Parkinson's disease: determining the genes necessary for optimal dopamine replacement in rat models.
Kang UJ; Lee WY; Chang JW
Hum Cell; 2001 Mar; 14(1):39-48. PubMed ID: 11436352
[TBL] [Abstract][Full Text] [Related]
14. Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration.
Lee WY; Lee EA; Jeon MY; Kang HY; Park YG
Exp Neurol; 2006 Jan; 197(1):215-24. PubMed ID: 16269145
[TBL] [Abstract][Full Text] [Related]
15. [Present status and future prospects for gene therapy in Parkinson's disease].
Muramatsu S
Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1461-6. PubMed ID: 13677895
[No Abstract] [Full Text] [Related]
16. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
17. Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats.
Björklund T; Hall H; Breysse N; Soneson C; Carlsson T; Mandel RJ; Carta M; Kirik D
J Neurochem; 2009 Oct; 111(2):355-67. PubMed ID: 19686242
[TBL] [Abstract][Full Text] [Related]
18. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors.
Fan DS; Ogawa M; Fujimoto KI; Ikeguchi K; Ogasawara Y; Urabe M; Nishizawa M; Nakano I; Yoshida M; Nagatsu I; Ichinose H; Nagatsu T; Kurtzman GJ; Ozawa K
Hum Gene Ther; 1998 Nov; 9(17):2527-35. PubMed ID: 9853519
[TBL] [Abstract][Full Text] [Related]
19. Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease.
Wachtel SR; Bencsics C; Kang UJ
J Neurochem; 1997 Nov; 69(5):2055-63. PubMed ID: 9349551
[TBL] [Abstract][Full Text] [Related]
20. L-Dopa and dopamine-producing gene cassettes for gene therapy approaches to Parkinson's disease.
Moffat M; Harmon S; Haycock J; O'Malley KL
Exp Neurol; 1997 Mar; 144(1):69-73. PubMed ID: 9126154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]